|
|
|
|
LEADER |
01000cam a2200265 4500 |
001 |
348372663 |
003 |
DE-627 |
005 |
20230905073759.0 |
007 |
tu |
008 |
020527s2002 sw ||||| m 00| ||eng c |
020 |
|
|
|a 9155452205
|9 91-554-5220-5
|
035 |
|
|
|a (DE-627)348372663
|
035 |
|
|
|a (DE-599)GBV348372663
|
035 |
|
|
|a (OCoLC)248725922
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
044 |
|
|
|c XA-SE
|
084 |
|
|
|a 44.38
|2 bkl
|
100 |
1 |
|
|a Sandström, Marie
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Pharmacokinetics and pharmacodynamics of anti-cancer regimens
|b emphasis on busulphan and the combination therapies epirubicin-docetaxal and fluorouracil-epirubicin-cyclophosphamide
|c Marie Sandström
|
264 |
|
1 |
|a Uppsala
|b AUU
|c 2002
|
300 |
|
|
|a 60 S
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
490 |
1 |
|
|a Comprehensive summaries of Uppsala dissertations from the Faculty of Pharmacy
|v 265
|
502 |
|
|
|a Zugl.: Uppsala, Univ., Diss., 2002
|
655 |
|
7 |
|a Hochschulschrift
|0 (DE-588)4113937-9
|0 (DE-627)105825778
|0 (DE-576)209480580
|2 gnd-content
|
689 |
0 |
0 |
|D s
|0 (DE-588)4073781-0
|0 (DE-627)104814144
|0 (DE-576)209191503
|a Krebs
|g Medizin
|2 gnd
|
689 |
0 |
1 |
|D s
|0 (DE-588)4115557-9
|0 (DE-627)105813400
|0 (DE-576)209494239
|a Pharmakokinetik
|2 gnd
|
689 |
0 |
2 |
|D s
|0 (DE-588)4147051-5
|0 (DE-627)105579696
|0 (DE-576)209753900
|a Busulfan
|2 gnd
|
689 |
0 |
3 |
|D s
|0 (DE-588)4113452-7
|0 (DE-627)105829382
|0 (DE-576)209476591
|a Epirubicin
|2 gnd
|
689 |
0 |
4 |
|D s
|0 (DE-588)4501869-8
|0 (DE-627)243928300
|0 (DE-576)213092980
|a Docetaxel
|2 gnd
|
689 |
0 |
5 |
|D s
|0 (DE-588)4154859-0
|0 (DE-627)105520071
|0 (DE-576)209814454
|a Fluorouracil
|2 gnd
|
689 |
0 |
6 |
|D s
|0 (DE-588)4148615-8
|0 (DE-627)104426314
|0 (DE-576)20976595X
|a Cyclophosphamid
|2 gnd
|
689 |
0 |
|
|5 (DE-627)
|
751 |
|
|
|a Uppsala
|4 uvp
|
810 |
2 |
|
|a Uppsala Universitet
|b Farmaceutiska Fakulteten
|t Comprehensive summaries of Uppsala dissertations from the Faculty of Pharmacy
|v 265
|9 265
|w (DE-627)129583227
|w (DE-576)017406641
|w (DE-600)233135-4
|x 0282-7484
|7 ns
|
912 |
|
|
|a GBV_ILN_20
|
912 |
|
|
|a ISIL_DE-84
|
912 |
|
|
|a SYSFLAG_1
|
912 |
|
|
|a GBV_KXP
|
912 |
|
|
|a SSG-OLC-PHA
|
912 |
|
|
|a SSG-OPC-PHA
|
912 |
|
|
|a SSG-OPC-DE-84
|
912 |
|
|
|a GBV_ILN_40
|
912 |
|
|
|a ISIL_DE-7
|
912 |
|
|
|a GBV_ILN_62
|
912 |
|
|
|a ISIL_DE-28
|
936 |
b |
k |
|a 44.38
|j Pharmakologie
|0 (DE-627)106409743
|
951 |
|
|
|a BO
|
980 |
|
|
|2 20
|1 01
|x 0084
|b 597288429
|c 00
|f --%%--
|d 2811-2886
|e --%%--
|j --%%--
|y k
|z 04-04-03
|
980 |
|
|
|2 40
|1 01
|x 0007
|b 556522400
|c 00
|f --%%--
|d K 2002 A 1024
|e u
|j --%%--
|y xsn
|z 27-05-02
|
980 |
|
|
|2 62
|1 01
|x 0028
|b 55959691X
|c 00
|f 28/BB1-MAG
|d ZA 6442 (265)
|e u
|j --%%--
|c 05
|f --%%--
|d VR 3100 C737-265
|e --%%--
|j --%%--
|y zbb1d
|z 26-06-02
|
984 |
|
|
|2 20
|1 01
|x 0084
|a 84$028112886
|
984 |
|
|
|2 40
|1 01
|x 0007
|a 7$211897264
|
984 |
|
|
|2 62
|1 01
|x 0028
|a 28$007514131
|
985 |
|
|
|2 62
|1 01
|x 0028
|a ZA 6442 (265)
|